PP_1170x120_10-25-21

Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioid

HDA’s statement on Inspector General’s DEA report

HDA’s statement on Inspector General’s DEA report

ARLINGTON, Va. — In response to the release of the U.S. Department of Justice Office of the Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, senior vice president of communications with the Healthcare Distribution Alliance (HDA) released the following statement last week: “Today’s